Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples

Timothy A. Bates; Hans C. Leier; Zoe L. Lyski; James R. Goodman; Marcel E. Curlin; William B. Messer; Fikadu G. Tafesse

doi:10.1001/jama.2021.11656

Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples

Timothy A. Bates, Hans C. Leier, Zoe L. Lyski, James R. Goodman, Marcel E. Curlin, William B. Messer, Fikadu G. Tafesse

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	868-869
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	326
Issue number	9
DOIs	https://doi.org/10.1001/jama.2021.11656
State	Published - Sep 7 2021

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1001/jama.2021.11656

Cite this

@article{141b2bf7f2eb4bb988c0f8905eb7595b,

title = "Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples",

author = "Bates, {Timothy A.} and Leier, {Hans C.} and Lyski, {Zoe L.} and Goodman, {James R.} and Curlin, {Marcel E.} and Messer, {William B.} and Tafesse, {Fikadu G.}",

note = "Funding Information: Biomedical Innovation Program during the conduct of the study. No other disclosures were reported. Funding/Support: This study was funded in part by an unrestricted grant from the M.J. Murdock Charitable Trust, by National Institutes of Health training grant T32AI747225 on Interactions at the Microbe-Host Interface, Oregon Health & Science University Innovative IDEA grant 1018784, and National Institutes of Health grant R01AI145835. Funding Information: Conflict of Interest Disclosures: Dr Curlin reported receiving grants from the M.J. Murdock Charitable Trust and the Oregon Health & Science University Foundation for unrestricted COVID-19 research during the conduct of the study. Dr Tafesse reported receiving grants from Oregon Health & Science University",

year = "2021",

month = sep,

day = "7",

doi = "10.1001/jama.2021.11656",

language = "English (US)",

volume = "326",

pages = "868--869",

journal = "JAMA - Journal of the American Medical Association",

issn = "0002-9955",

publisher = "American Medical Association",

number = "9",

}

TY - JOUR

T1 - Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples

AU - Bates, Timothy A.

AU - Leier, Hans C.

AU - Lyski, Zoe L.

AU - Goodman, James R.

AU - Curlin, Marcel E.

AU - Messer, William B.

AU - Tafesse, Fikadu G.

N1 - Funding Information: Biomedical Innovation Program during the conduct of the study. No other disclosures were reported. Funding/Support: This study was funded in part by an unrestricted grant from the M.J. Murdock Charitable Trust, by National Institutes of Health training grant T32AI747225 on Interactions at the Microbe-Host Interface, Oregon Health & Science University Innovative IDEA grant 1018784, and National Institutes of Health grant R01AI145835. Funding Information: Conflict of Interest Disclosures: Dr Curlin reported receiving grants from the M.J. Murdock Charitable Trust and the Oregon Health & Science University Foundation for unrestricted COVID-19 research during the conduct of the study. Dr Tafesse reported receiving grants from Oregon Health & Science University

PY - 2021/9/7

Y1 - 2021/9/7

UR - http://www.scopus.com/inward/record.url?scp=85111402147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85111402147&partnerID=8YFLogxK

U2 - 10.1001/jama.2021.11656

DO - 10.1001/jama.2021.11656

M3 - Letter

C2 - 34287620

AN - SCOPUS:85111402147

SN - 0002-9955

VL - 326

SP - 868

EP - 869

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 9

ER -

Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this